Report post

When did Cellect biotechnology shares split?

Cellect Biotechnology shares split on the morning of Tuesday, October 26th 2021. The 2-1 split was announced on Tuesday, October 26th 2021. The newly minted shares were issued to shareholders after the market closes on Tuesday, October 26th 2021. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

Is Cellect Biotechnology Ltd a delisted company?

Notice: This company has been marked as potentially delisted and may not be actively trading. Cellect Biotechnology Ltd. engages in the provision of regenerative medicine. Its activities include development of regenerative medicine through the development of products facilitating immune stem cell selection.

Which companies do Cellect biotechnology investors own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Cellect Biotechnology investors own include Elbit Systems (ESLT), Gilead Sciences (GILD), Pluristem Therapeutics (PSTI), NVIDIA (NVDA), Teva Pharmaceutical Industries (TEVA), Acasti Pharma (ACST), Allergan (AGN), Novavax (NVAX) and RedHill Biopharma (RDHL).

The World's Leading Crypto Trading Platform

Get my welcome gifts